τϊιηϊ ϊτψιθ πβιωεϊ
βιωδ ξδιψδ μγσ δαιϊ

φιτεψπι ηϊεμ τψεΰπιιν, ΰεπχψιδ - Uncaria tomentosa

ςεγλο αϊΰψικ 17/02/2019

Uña de gato, Cat’s Claw


ξωτηδ αεθπιϊ: τεΰϊιιν – Rubiaceae

ημχ δφξη | ΰιλειεϊ | ψλιαιν τςιμιν | δϊεειεϊ | ξιπεπιν | ψβιωεϊ | ϊετςεϊ μεεΰι | 

ξιπεο ιϊψ | ΰζδψεϊ | δϊεειεϊ πβγ | ψςιμεϊ | ΰιπθψΰχφιεϊ | δψιεο | δπχδ

 

φΔιτεψπι ηϊεμ τψεΰπιιν πχψΰ λκ ςμ ων δχεφιν δξΰεπχμιν δξςθψιν ΰϊ δφξη μΰεψλε. 

ξθςξι πεηεϊ, μΰεψκ δξεπεβψσ ΰπε ξωϊξωιν αων δαεθπι ΧΰεπχψιδΧ εμΰ αων δςαψι δΰψεκ Χφāιτεψπι ηϊεμ τψεΰπιινΧ, δξαγιμ ΰϊ δφξη ξΧφΔιτεψπι ηϊεμΧ (Calendula officinalis).

ιω μφιιο λι ϊξφιεϊ ΰεπχψιδ μςιϊιν ςμεμεϊ μδλιμ ωιμεα αιο δξιο U. tomentosa μξιο U. guianensis, ΰεμν ξεπεβψσ ζδ ξϊιιηρ μαθιηεϊ ειςιμεϊ δωιξεω αξιο U. tomentosa αμαγ.

ΰεπχψιδ διπε φξη ξθτρ ξςεφδ (liana). ξεφΰε αβΧεπβμιν δθψετιιν ωαξψλζ εγψεν ΰξψιχδ (αςιχψ ιςψ δΰξζεπρ).

ΰεπχψιδ ξεϊψ μωιεεχ αιωψΰμ.

 

ημχ δφξη αωιξεω

χμιτϊ βζς, χμιτϊ ωεψω.

 

ΰιλειεϊ

θξτψθεψδ: χψ.

μηεϊ: ιαω.

θςν: ξψ, φεψα.

 

ψλιαιν τςιμιν ςιχψιιν

ΰμχμεΰιγιν ΰεχριπγεμιιν* εΰιπγεμιιν (0.15-4.60% ρκ δλμ, πημχιν μτπθφιχμιιν λβεο formosanine (uncarine B), pteropodine (uncarine C), isopteropodine (uncarine E), speciophylline (uncarine D), uncarine F, mitraphylline, isomitraphylline ΰε θθψφιχμιιν, αιπιδν rhynchophylline ε-isorhynchophylline), θψιθψτπιν (quinovic acid = tomentoside A, B, Ursolic acid, uncaric acid, oleanolic acid, floridic acid, cincholic acid), τψεΰπϊεφιΰπιπιν, ρθψεμιν (β-sitosterol, stigmasterol, campesterol).

 

*ϊλεμϊ δΰμχμεΰιγιν ςμεμδ μδωϊπεϊ αΰετο ξωξςεϊι λϊμεϊ αωιθεϊ βιγεμ εςιϊει δχφιψ(1-3). ρκ δΰμχμεΰιγιν αχμιτϊ δωεψω διαωδ ςμεμ μδωϊπεϊ αθεεη ωμ 0.036-3.83% αδϊΰν μϊχετϊ δχφιψ(3). χιιξιν ωπι ζπιν αςμι θιτεριν λιξιιν (chemotype) ωεπιν ωμ ΰεπχψιδ; δΰηγ ξλιμ αςιχψ ΰμχμεΰιγιν ΰεχριπγεμιιν τπθφιχμιιν (POA), εδωπι ςωιψ αΰμχμεΰιγιν ΰεχριπγεμιιν θθψφιχμιιν (TOA). φξη ρτφιτι ςωει μδωϊπεϊ ςν δζξο εμδημισ ξγτερ ΰμχμεΰιγιν ΰηγ μΰηψ(3). ςψαεα αιο ωπι θιτερι ΰεπχψιδ ωεπιν πξφΰ μΰ ξϊΰιν μωιξεω ψτεΰι, ΰμΰ ΰν ϊλεμϊ δ-TOA χθπδ ξ-0.02% αξεφψ δρετι; πξφΰ ω-TAO ρεϊψιν ΰϊ δτςιμεϊ δψτεΰιϊ ωμ ΰμχμεΰιγιν ξρεβ POA (δςμΰϊ ψξεϊ μειχεφιθιν)(1,4-6).

 

δϊεειεϊ

ωιξεω τπιξι – ζιδεξιν ΰχεθιιν, ΰιιγρ, δψτρ εζιδεξι ωμαχϊ, ξημϊ δπωιχδ (ξεπεπεχμιΰεζιρ, EBV), ϊρξεπϊ δςιιτεϊ δλψεπιϊ (CFS), γμχϊ ξτψχιν ωβψεπιϊ (RA), γμχϊ ξτψχιν πιεεπιϊ (OA), ρψθο, ωτςϊ, δφθππεϊ, γμχϊ ψιΰεϊ, ριπεριθιρ, χπγιγδ.

ωιξεω ηιφεπι – δψτρ.

 

ξιπεπιν 

ϊξφιϊ πεζμιϊ αψιλεζ 1:3, 45% ΰμλεδεμ – 6-18 ξΨμ αιεν. 

ϊξφιϊ ιαωδ – ϊμει αψιλεζ δϊξφιϊ. ξιπεο δξχαιμ μ- 2-6 βψν φξη αιεν.

ξψϊη – 2-15 βψν αιεν. 

ατεψξεμδ – 20-30%.

 

ψβιωεϊ

μΰ ιγεςδ ψβιωεϊ ξιεηγϊ μΰεπχψιδ.

 

ϊετςεϊ μεεΰι

αϊηιμϊ δωιξεω αΰεπχψιδ ςμεμεϊ μδετις  μξιγς δωμν μξπειιν

μωιξεω αϊξφιεϊ δξλιμεϊ αςιχψ TOA ςμεμεϊ μδϊμεεϊ  μξιγς δωμν μξπειιν

μωιξεω αϊξφιεϊ δξλιμεϊ αςιχψ POA ςμεμδ μδϊμεεϊ ςμιδ χμδ α  μξιγς δωμν μξπειιν

ςν ζΰϊ, αξηχψιν χμιπιιν ωεπιν  μξιγς δωμν μξπειιν

χιιν γιεεη ξχψδ αεγγ ΰεγεϊ ηεμδ τψχιπρεο αο 38 ωηεεδ  μξιγς δωμν μξπειιν

 

ξιπεο ιϊψ

μτι δψτεΰδ δτψεΰπιϊ δξρεψϊιϊ, ξιπεο βαεδ ωμ ξψϊηι χμιτϊ βζς ωμ ΰεπχψιδ ςμεμ μβψεν μ  μξιγς δωμν μξπειιν

 

ΰζδψεϊ εφςγι ξπς

ξημεϊ ΰεθεΰΔιξεπιεϊ – ιω μπχεθ ζδιψεϊ ψαδ αωιξεω αΰεπχψιδ αχψα ΰπωιν δρεαμιν ξξημεϊ ΰεθεΰιξεπιεϊ, εαξιεηγ αωιξεω ΰψεκ θεεη αξθετμιν ΰμε(7,14).

χιιν γιεεη ξχψδ αεγγ ΰεγεϊ ηεμϊ ζΰαϊ ΰγξπϊιϊ ξςψλϊιϊ (SLE) αϊ 35 ωηεεϊδ  μξιγς δωμν μξπειιν

ςν ζΰϊ, αξηχψ χμιπι ωλμμ πθιμϊ 60 ξΨβ ϊξφιϊ ωεψω ΰεπχψιδ (POA) ςμ-ιγι 40 ηεμι γμχϊ ξτψχιν ωβψεπιϊ (RA), πφτϊδ  μξιγς δωμν μξπειιν

ϊεφΰεϊ γεξεϊ πφτε αξηχψ χμιπι περσ, ψπγεξμι, ξαεχψ-τμραε εψα-ξψλζιν(11). αξηχψ ζδ δωϊϊτε 60 παγχιν, ωπθμε 900 ξΨβ ϊξφιϊ ΰεπχψιδ (ψιλεζ μΰ ιγες) αιεν ΰε τμραε, αξωκ 6 ηεγωιν.

δμιλιν λιψεψβιιν – ξεξμυ μδτριχ ΰϊ πθιμϊ δφξη (εαξιεηγ ϊξφιεϊ TOA) λ- 10-14 ιξιν μτπι δμιλιν λιψεψβιιν. αξηχψιν ωπςψλε αϊπΰι ξςαγδ εαχψα αςμι ηιιν, μξιγς δωμν μξπειιν

 

δϊεειεϊ πβγ

ιφψπι ϊξφιεϊ ξαερρεϊ POA ωμ ΰεπχψιδ ΰιπν ξξμιφιν ςμ ωιξεω αϊλωιψιν ΰμε αχψα ΰπωιν ωχιαμε ΰε ςϊιγιν μχαμ  μξιγς δωμν μξπειιν

δωιξεω αϊξφιεϊ ωεψω ΰεπχψιδ ΰρεψ αψηαι ΰιψετδ μ  μξιγς δωμν μξπειιν

 

ψςιμεϊ

αξηχψιν χμιπιιν μΰ πφτϊδ λμ ςγεϊ μψςιμεϊ ΰε πζχ αςχαεϊ ωιξεω αΰεπχψιδ αξιπεπιν δψτεΰιιν δξχεαμιν(1,11,23-26).

αξρτψ ξηχψιν ωπςψλε αχψα ξλψρξιν, μΰ πφτϊδ ψςιμεϊ ΰε πζχ αςχαεϊ φψιλδ τεξιϊ ωμ ϊξφιεϊ ΰεπχψιδ αξιπεπιν δπςιν αιο  μξιγς δωμν μξπειιν

ξγγ ψςιμεϊ LD50:  μξιγς δωμν μξπειιν

 

ϊβεαεϊ δγγιεϊ ςν ϊψετεϊ / φξηι ξψτΰ / ϊερτι ϊζεπδ

 

δωτςδ ςμ ηιμεσ ηεξψιν ϊψετϊι  μξιγς δωμν μξπειιν

 

θιτεμιν ηιρεπιιν ε/ΰε ωξχεψν ααςμι ηιιν  μξιγς δωμν μξπειιν

 

ξςλαι τψεθΰζεϊ (Atazanavir, Ritonavir, Saquinavir)  μξιγς δωμν μξπειιν

 

λιξεϊψτιδ (FOLFOX-4, FAC)  μξιγς δωμν μξπειιν

 

θιτεμ ϊψετϊι χεπαπφιεπΰμι μγμχϊ ξτψχΔιν ωβψεπιϊ (RA)  μξιγς δωμν μξπειιν

 

ηιρεο ξεξϊ (τπΰεξεχεχ)  μξιγς δωμν μξπειιν

 

ϊψετεϊ πεβγεϊ χψιωδ  μξιγς δωμν μξπειιν

 

ϊψετεϊ μδεψγϊ μηυ γν  μξιγς δωμν μξπειιν

 

ϊψετεϊ πεβγεϊ ηψγδ μξιγς δωμν μξπειιν

 

δψιεο

ΰεπχψιδ ΰρεψ μωιξεω αξδμκ δδψιεο εαχψα πωιν ωξϊλππεϊ μδιλπρ μδψιεο(7,8,15,15,40).

αψτεΰδ δτψεΰπιϊ δξρεψϊιϊ, πςωδ ωιξεω αξιπεπιν βαεδιν ωμ ξψϊηι ΰεπχψιδ λ  μξιγς δωμν μξπειιν

αξηχψιν ωπςψλε αχψα ςλαψιν πφτϊδ  μξιγς δωμν μξπειιν

λξε λο, πθιμδ τεξιϊ ωμ δξιπεπιν δξγεαψιν εΰσ πξελιν ιεϊψ  μξιγς δωμν μξπειιν

 

δπχδ

ηρψ ξιγς απεωΰ.

ιφψπι ϊξφιεϊ ξαερρεϊ POA ωμ ΰεπχψιδ ΰιπν ξξμιφιν ςμ ωιξεω αϊλωιψιν ΰμε αχψα πωιν ξπιχεϊ, ςχα  μξιγς δωμν μξπειιν

ςν ζΰϊ, αψτεΰδ δτψεΰπιϊ δξρεψϊιϊ πςωδ ωιξεω αφξη λγι  μξιγς δωμν μξπειιν

αξιγδ επςωδ ωιξεω αΰεπχψιδ αξδμκ δδπχδ, ιω μςωεϊ λο αξωπδ ζδιψεϊ εϊηϊ τιχεη ξχφεςι αμαγ(7,8,14,15,21).

 

 

ξχεψεϊ

  1. European Medicines Agency. Assessment report on Uncaria tomentosa (Willd. ex Schult.) DC., cortex. Committee on Herbal Medicinal Products (HMPC). 10 March 2015. Available here. 
  2. Kemper K. J. Cat’s Claw (Uncaria tomentosa). Longwood Herbal Task Force 1999, 1-13
  3. Laus G, Keplinger K. Separation of stereoisomeric oxindole alkaloids from Uncaria tomentosa by high performance chromatography. Journal of Chromatography 1994, 662:243 249
  4. Wurm M, Kacani L, Laus G, Keplinger K, Dierich MP. Pentacyclic oxindole alkaloids from Uncaria tomentosa induce human endothelial cells to release a lymphocyte-proliferation-regulating factor. Planta Medica 1998, 64(8):701-704
  5. Laus G, Keplinger K. Radix Uncariae tomentosae (Wild.) DC. Zeitschrift für Phytotherapie 1997, 18:122-126
  6. Barnes J, Anderson LA, Phillipson JD. Herbal Medicines. 2nd ed. Pharmaceutical Press, London, Chicago 2002
  7. Mills. S, Bone K, The Essential Guide to Herbal Safety. Churchill Livingstone, 2005
  8. Reinhard KH. Uncaria tomentosa (Willd.) D.C Cat’s Claw, Una de Gato or Savéntero. The Journal of Alternative and Complementary Medicine 1999, 2:143-151
  9. Obregón Vilches LE: Cat's claw: Uncaria genus. Botanical, chemical, and pharmacological studies of Uncaria tomentosa and Uncaria guianensis, English ed, Lima, 1995, Instituto de Fitoterapia Americano, p 124.
  10. Mur E, Hartig F, Eibl G Schirmer M. Randomized Double Blind Trial o fan extract from the Pentacyclic Alkaloid-Chemotype of Uncaria tomentosa for the Treatment of Rheumatoid Arthritis. The Journal of Rheumatology 2002, 29:678-81
  11. Castañeda DO, León G, León D, Calvo A, Chávez J, Escalante J et al. Uña de Gato en Artritis Reumatoide: Estudio doble ciego, en comparación con placebo. Revista Peruana de Reumatología 1998, 4(1):15-21 [Spanish]
  12. Cosentino C, Torres L. Reversible worsening of Parkinson disease motor symptoms after oral intake of Uncaria tomentosa (cat's claw). Clinical Neuropharmacology 2008, 31(5):293-294
  13. Jones K: Cat's claw: healing vine of Peru, Seattle, 1995, Sylvan Press, p 29. 
  14. Brinker F. Herb Contraindications and Drug Interactions, 4th ed. Sandy (OR): Eclectic Medical Publications; 2010
  15. Williams JE. Review of Antiviral and immunomodulating properties of plants of the Peruvian rainforest with a particular emphasis on una de gato and sangre de grado. Altern. Med. Rev., 6(6):567-579, 2001
  16. Hilepo JN, Bellucci AG, Mossey RT. Acute renal failure caused by ’cat’s claw’ herbal remedy in a patient with systemic lupus erythematosus. Nephron. 1997;77(3):361.
  17. Erowele GI, Kalejaiye AO. Pharmacology and therapeutic uses of cat's claw. Am. J. Health-Syst. Pharm., 66:992-995, 2009
  18. Zhou, J. Y. and Zhou, S. W. Isorhynchophylline: A plant alkaloid with therapeutic potential for cardiovascular and central nervous system diseases. Fitoterapia 2012;83(4):617-626.
  19. Chen, C. X., Jin, R. M., Li, Y. K., Zhong, J., Yue, L., Chen, S. C., and Zhou, J. Y. Inhibitory effect of rhynchophylline on platelet aggregation and thrombosis. Zhongguo Yao Li Xue.Bao. 1992;13(2):126-130.
  20. Immodal Pharmaka: Krallendorn®. Uncaria tomentosa (Willd.) DC. mod. pent. root extract. Report on experiences with probands. Volders/Tirol, Austria,1996, Immodal Pharmaka GmbH, pp 1-20.
  21. McGuffin M, Hobbs C, Upton R, Goldberg A (ed.). Botanical Safety Handbook. CRC Press, Boca Raton, 1997
  22. Jones K: Cat's claw: healing vine of Peru, Seattle, 1995, Sylvan Press, p 46.
  23. Farias I, Araujo MdoCS, Zimmermann ES, Dalmora SL, Benedetti AL, Alvarez-Silva M, et al. Uncaria tomentosa stimulates the proliferation of myeloid progenitor cells. Journal of Ethnopharmacology 2011, 137(1):856-863
  24. Sheng Y, Bryngelsson C, Pero RW. Enhanced DNA repair, immune function and reduced toxicity of C- MED-100TM, a novel aqueous extract from Uncaria tomentosa. Journal of Ethnopharmacology 2000a, 69(2):115–126
  25. Sheng Y, Li L, Holmgren K, Pero R.W. DNA repair enhancement of aqueous extracts of Uncaria tomentosa in a human volunteer study. Phytomedicine 2001, 8(4):275–282
  26. Lamm S, Sheng Y, Pero RW. Persistent response to pneumococcal vaccine in individuals supplemented with a novel water soluble extract of Uncaria tomentosa, C-Med-100®. Phytomedicine 2001, 8(4):267– 274
  27. Pino A, Salazar M, Vargas K, et al: 2nd International Congress on Phytomedicine and 7th Congress of the German Society of Phytotherapy in cooperation with ESCOP (European Scientific cooperative for Phytotherapy). September 11-14, 1996. Munich, Germany. Abstract no SL-18.
  28. Svendson O, Skydsgaard K: Test report: extractum radicis Uncariae tomentosae, Denmark, 1986, Scantox Biological Laboratory, cited in Keplinger K, Laus G, Wurm M, et al: J Ethnopharmacol 64:23-34, 1999.
  29. Ibrahim KE, Al-Ashban RM, El-Sammani SA. A Study of the Toxicity of Cat’s Claw Herbal Medicine.Research Journal of Pharmacology 2009, 3(3):52-57
  30. Keplinger K, Laus G, Wurm M, Dierich MP, Teppner H. Uncaria tomentosa (Willd.) DC.—Ethnomedicinal use and new pharmacological, toxicological and botanical results. Journal of Ethnopharmacology 1999, 64(1):23–34
  31. Kynock SR, Lloyd GK: Acute oral toxicity to mice of substance E-2919, Huntingdon, 1975, Huntington Research Centre, cited in Reinhard KH: J Altern Complement Med 1999; 5(2): 143-151.
  32. Valerio LG Jr, Gonzales GF. Toxicological Aspects of the South American Herbs Cat’s Claw (Uncaria tomentosa) and Maca (Lepidium meyenii). A Critical synopsis. Toxicological Reviews 2005, 24(1):11-35
  33. Budzinski JW, Foster BC, Vandenhoek S, Arnason JT. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine. 2000 Jul;7(4):273-82.
  34. Sato Y, Sasaki T, Takahashi S, Kumagai T, Nagata K. Development of a highly reproducible system to evaluate inhibition of cytochrome P450 3A4 activity by natural medicines. J Pharm Pharm Sci. 2015 Nov;18(4):316-27.
  35. Lopez Galera RM, Ribera Pascuet E, Esteban Mur JI, et al. Interaction between cat’s claw and protease inhibitors atazanavir, ritonavir and saquinavir. Eur J Clin Pharmacol. Dec 2008;64(12):1235-1236.
  36. Araújo MdoCS, Farias IL, Gutierres J, Dalmora SL, Flores N, Farias J et al. Uncaria tomentosa-Adjuvant Treatment for Breast Cancer: Clinical Trial. Evidence-based Complementary and Alternative Medicine 2012, Article ID:676984, 8 pages, doi:10.1155/2012/676984
  37. Farias IL, Araújo MdoCS, Farias JG.,Rossato LV, Elsenbach LI, Dalmora SL, et al. Uncaria tomentosa for Reducing Side Effects Caused by Chemotherapy in CRC Patients: Clinical Trial. Evidence-Based Complementary and Alternative Medicine 2012, Article ID 892182, 8 pages, doi:10.1155/2012/89218
  38. Sheng Y, Pero RW, Wagner H. Treatment of chemotherapy-induced leukopenia in a rat model with aqueous extract from Uncaria tomentosa. Phytomedicine. 2000 Apr;7(2):137-43.
  39. Dietrich F, Pietrobon Martins J, Kaiser S, Madeira Silva RB, Rockenbach L, Albano Edelweiss MI, Ortega GG, Morrone FB, Campos MM, Battastini AM. The Quinovic Acid Glycosides Purified Fraction from Uncaria tomentosa Protects against Hemorrhagic Cystitis Induced by Cyclophosphamide in Mice. PLoS One. 2015 Jul 8;10(7):e0131882. ECollection 2015.
  40. Farnsworth NR, Bingel AS, Cordell GA, et al. Potential value of plants as sources of new antifertility agents I. J. Pharm. Sci., 64:535-598, 1975
  41. De Feo V: Fitoterapia 63:417-440, 1992.
  42. Obregón Vilches LE: Cat's claw: Uncaria genus. Botanical, chemical, and pharmacological studies of Uncaria tomentosa and Uncaria guianensis, English ed, Lima, 1995, Instituto de Fitoterapia Americano, p 124.
  43. Jones K: Cat's claw: healing vine of Peru, Seattle, 1995, Sylvan Press, p 64.
  44. Taylor L. Herbal Secrets of the Rainforests 2nd ed. Sage Press, Inc., Austin, TX, USA 2002
  45. Cabieses F. The Saga of the Cat’s Claw. Via Lactera Editores, Lima 1994
  46. Rain-tree Tropical Plant database, Uncaria tomentosa, Cat’s Claw. The text has been printed from “The Healing Power of Rainforest Herbs “ by Leslie Taylor, copyrighted Š 2004. Available here. Accessed 09/20/2014
  47. Keplinger K: Composition allowing for modifying the growth of living cells, preparation and utilization of such a composition [in german], international Patent WO8201130, April 1982. 
  48. Iziga R, Gutierrez-Pajares J, Pino J: Boletin de la Sociedad de Biologia de Concepcion 69:141-145, 1998. 
  49. Keplinger K: Cytostat, contraceptive, and antiinflammatory agent from Uncaria tomentosa roots, PCT Int.Appl. WO 821130 A1,April 1982.
  50. McKenna DJ, Jones K, Hughes K, Humphrey S, editors. Botanical Medicines. The desk reference for Major Herbal Supplements. 2nd ed. The Haworth Herbal Press, Binghampton, NY, USA 2002
  51. Nogueira Neto J, Cavalcante FL, Carvalho RA, Rodrigues TG, Xavier MS, Furtado PG, Schor E. Contraceptive effect of Uncaria tomentosa (cat's claw) in rats with experimental endometriosis. Acta Cir Bras. 2011;26 Suppl 2:15-9.
  52. Jones K: Cat's claw: healing vine of Peru, Seattle, 1995, Sylvan Press, p 25.
  53. Choi JG, Eom SM, Kim J, et al., A Comprehensive Review of Recent Studies on Herb-Drug Interaction: A Focus on Pharmacodynamic Interaction. J Altern Complement Med. 2016 Apr;22(4):262-79. https://www.ncbi.nlm.nih.gov/pubmed/27003511
  54. Quı’lez AM, Saenz MT, Garcı’a MD. Uncaria tomentosa (Willd. ex. Roem. & Schult.) DC. and Eucalyptus globulus Labill. interactions when administered with diazepam. Phytother Res 2012;26:458–461. https://www.ncbi.nlm.nih.gov/pubmed/21928376
     

γεβξΰ μξεπεβψσ ξμΰ

μψλιωϊ ξπει  |  λπιρϊ ξπειιν

αηζψδ μγσ δψΰωι ωμ δΰιπγχρ

ηζψδ μϊηιμϊ δςξεγ

ηζψδ μςξεγ δχεγν